Skip to main content
Top
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Diabetic Foot | Research

Economic burden of diabetic foot ulcer: a case of Iran

Authors: Reza Hashempour, SeyedHadi MirHashemi, Fariba Mollajafari, Soheila Damiri, Ali ArabAhmadi, Behzad Raei

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Diabetic foot ulcer (DFU) is known as a serious complication of diabetes mellitus in patients with diabetes, imposing heavy medical costs on healthcare systems due to its chronic nature. patients with severe diabetic foot ulcer are often disabled to work, and some of them may even die, leading to associated productivity losses. Since no previous study has investigated the economic burden of DFU in Iran, this study is to estimate the economic burden of diabetic foot disease in Iran.

Methods

In this descriptive cross-sectional study, randomly selected samples consisted of 542 patients with DFU, hospitalized in the hospitals of Shahid Beheshti University of Medical Sciences. The demographic profile and cost data used in this analysis were derived from a researcher-designed checklist. Lost productivity was calculated based on Human Capital Approach, and the total economic cost of DFU was determined using patient-level data on costs and prevalence data from the global burden of diseases reports. All analyses were performed using SPSS software (Version 23), and Microsoft Excel (Version 19).

Results

The economic burden of DFU in Iran in two scenarios of discounting future costs and not discounting them was about $8.7 billion and $35 billion, respectively (about 0.59 and 2.41% of GDP). 79.25% of the estimated costs in this study were indirect costs and productivity losses, of which 99.34% (7,918.4 million Dollars) were productivity losses due to premature death. 20.75% (2,064.4 million dollars) of the estimated costs in this study were direct costs. The average length of stay (LOS) was 8.10 days (SD = 9.32), and 73.3% of patients recovered and were discharged after hospitalization and 7.6% died. The majority of the costs are imposed on the age group of 60–69 year (53.42% of the productivity lost due to hospital length of stay, 58.91% of the productivity lost due to premature death & 40.41% of direct costs).

Conclusions

DFU represents a heavy burden to patients, Iran’s health system, and the economy. Early prevention strategies need to be prioritized in making public health policies. These policies and decisions can be in the area of changing lifestyle, health education, changing people's behavior, and encouraging physical activity that targeted high-risk populations in order to reduce the prevalence of diabetic foot and resulting substantial economic burden.
Literature
1.
go back to reference Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20:1–9.CrossRef Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20:1–9.CrossRef
2.
go back to reference Mariam TG, Alemayehu A, Tesfaye E, Mequannt W, Temesgen K, Yetwale F, et al. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional-based cross-sectional study. J Diabetes Res. 2017;2017:2879249. https://doi.org/10.1155/2017/2879249. Mariam TG, Alemayehu A, Tesfaye E, Mequannt W, Temesgen K, Yetwale F, et al. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional-based cross-sectional study. J Diabetes Res. 2017;2017:2879249. https://​doi.​org/​10.​1155/​2017/​2879249.
3.
go back to reference Lu Q, Wang J, Wei X, Wang G, Xu Y, Lu Z, et al. Cost of diabetic foot ulcer management in China: a 7-year single-center retrospective review. Diabetes Metab Syndr Obes. 2020;13:4249–60.PubMedPubMedCentralCrossRef Lu Q, Wang J, Wei X, Wang G, Xu Y, Lu Z, et al. Cost of diabetic foot ulcer management in China: a 7-year single-center retrospective review. Diabetes Metab Syndr Obes. 2020;13:4249–60.PubMedPubMedCentralCrossRef
4.
go back to reference Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimani M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:1–8.CrossRef Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimani M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:1–8.CrossRef
5.
go back to reference Toscano CM, Sugita TH, Rosa MQ, Pedrosa HC, Rosa RdS, Bahia LR. Annual direct medical costs of diabetic foot disease in Brazil: a cost of illness study. Int J Environ Res Public Health. 2018;15(1):89.PubMedPubMedCentralCrossRef Toscano CM, Sugita TH, Rosa MQ, Pedrosa HC, Rosa RdS, Bahia LR. Annual direct medical costs of diabetic foot disease in Brazil: a cost of illness study. Int J Environ Res Public Health. 2018;15(1):89.PubMedPubMedCentralCrossRef
6.
go back to reference Woods T-J, Tesfay F, Speck P, Kaambwa B. Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: a systematic review. PLoS One. 2020;15(4):e0232395.PubMedPubMedCentralCrossRef Woods T-J, Tesfay F, Speck P, Kaambwa B. Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: a systematic review. PLoS One. 2020;15(4):e0232395.PubMedPubMedCentralCrossRef
7.
go back to reference Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Kamath P, et al. Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113.PubMedCrossRef Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Kamath P, et al. Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113.PubMedCrossRef
8.
go back to reference Ahmadishooli A, Davoodian P, Shoja S, Ahmadishooli B, Dadvand H, Hamadiyan H, et al. Frequency and antimicrobial susceptibility patterns of diabetic foot infection of patients from Bandar Abbas District. Southern Iran J Pathog. 2020;2020:1057167.PubMed Ahmadishooli A, Davoodian P, Shoja S, Ahmadishooli B, Dadvand H, Hamadiyan H, et al. Frequency and antimicrobial susceptibility patterns of diabetic foot infection of patients from Bandar Abbas District. Southern Iran J Pathog. 2020;2020:1057167.PubMed
9.
go back to reference Asadi-Samani M, Moradi M-T, Mahmoodnia L, Alaei S, Asadi-Samani F, Luther T. Traditional uses of medicinal plants to prevent and treat diabetes; an updated review of ethnobotanical studies in Iran. J Nephropathol. 2017;6(3):118.PubMedPubMedCentralCrossRef Asadi-Samani M, Moradi M-T, Mahmoodnia L, Alaei S, Asadi-Samani F, Luther T. Traditional uses of medicinal plants to prevent and treat diabetes; an updated review of ethnobotanical studies in Iran. J Nephropathol. 2017;6(3):118.PubMedPubMedCentralCrossRef
10.
go back to reference Muhammad FY, Pedro LM, Suleiman HH, Uloko AE, Gezawa ID, Adenike E, et al. Cost of illness of diabetic foot ulcer in a resource limited setting: a study from Northwestern Nigeria. J Diabetes Metab Disord. 2018;17:93–9.PubMedPubMedCentralCrossRef Muhammad FY, Pedro LM, Suleiman HH, Uloko AE, Gezawa ID, Adenike E, et al. Cost of illness of diabetic foot ulcer in a resource limited setting: a study from Northwestern Nigeria. J Diabetes Metab Disord. 2018;17:93–9.PubMedPubMedCentralCrossRef
11.
go back to reference Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):1–4.PubMedPubMedCentralCrossRef Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):1–4.PubMedPubMedCentralCrossRef
12.
go back to reference Kerr M, Barron E, Chadwick P, Evans T, Kong W, Rayman G, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995–1002.PubMedCrossRef Kerr M, Barron E, Chadwick P, Evans T, Kong W, Rayman G, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995–1002.PubMedCrossRef
13.
go back to reference Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519–24.PubMedCrossRef Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519–24.PubMedCrossRef
14.
go back to reference Mahmoodi H, Abdi K, Navarro-Flores E, Karimi Z, Sharif Nia H, Gheshlagh RG. Psychometric evaluation of the Persian version of the diabetic foot self-care questionnaire in Iranian patients with diabetes. BMC Endocr Disord. 2021;21(1):72.PubMedPubMedCentralCrossRef Mahmoodi H, Abdi K, Navarro-Flores E, Karimi Z, Sharif Nia H, Gheshlagh RG. Psychometric evaluation of the Persian version of the diabetic foot self-care questionnaire in Iranian patients with diabetes. BMC Endocr Disord. 2021;21(1):72.PubMedPubMedCentralCrossRef
15.
go back to reference Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One. 2011;6(10):e26864.PubMedPubMedCentralCrossRef Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One. 2011;6(10):e26864.PubMedPubMedCentralCrossRef
16.
go back to reference Aalaa M, Sanjari M, Mohajeri-Tehrani MR, Mehrdad N, Amini MR. A multidisciplinary team approach in Iranian diabetic foot research group. J Diabetes Metab Disord. 2019;18:721–3.PubMedPubMedCentralCrossRef Aalaa M, Sanjari M, Mohajeri-Tehrani MR, Mehrdad N, Amini MR. A multidisciplinary team approach in Iranian diabetic foot research group. J Diabetes Metab Disord. 2019;18:721–3.PubMedPubMedCentralCrossRef
17.
go back to reference Lo ZJ, Lim X, Eng D, Car J, Hong Q, Yong E, et al. Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review. Int Wound J. 2020;17(3):790–803.PubMedPubMedCentralCrossRef Lo ZJ, Lim X, Eng D, Car J, Hong Q, Yong E, et al. Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review. Int Wound J. 2020;17(3):790–803.PubMedPubMedCentralCrossRef
18.
go back to reference Öien R, Ragnarson TG. Accurate diagnosis and effective treatment of leg ulcers reduce prevalence, care time and costs. J Wound Care. 2006;15(6):259–62.PubMedCrossRef Öien R, Ragnarson TG. Accurate diagnosis and effective treatment of leg ulcers reduce prevalence, care time and costs. J Wound Care. 2006;15(6):259–62.PubMedCrossRef
19.
go back to reference Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Heal Econ Rev. 2012;2(1):18.CrossRef Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Heal Econ Rev. 2012;2(1):18.CrossRef
20.
go back to reference Afkar A, Jalilian H, Pourreza A, Mir H, Sigaroudi AE, Heydari S. Cost analysis of breast cancer: a comparison between private and public hospitals in Iran. BMC Health Serv Res. 2021;21(1):1–11.CrossRef Afkar A, Jalilian H, Pourreza A, Mir H, Sigaroudi AE, Heydari S. Cost analysis of breast cancer: a comparison between private and public hospitals in Iran. BMC Health Serv Res. 2021;21(1):1–11.CrossRef
21.
go back to reference Yousefi M, Assari Arani A, Sahabi B, Kazemnejad A, Fazaeli S. Household health costs: direct, indirect and Intangible. Iran J Public Health. 2014;43(2):202–9.PubMedPubMedCentral Yousefi M, Assari Arani A, Sahabi B, Kazemnejad A, Fazaeli S. Household health costs: direct, indirect and Intangible. Iran J Public Health. 2014;43(2):202–9.PubMedPubMedCentral
22.
go back to reference Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disease and Injury Burden 1990–2019 Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME). 2020. Available from: https://vizhub.healthdata.org/gbd-results/. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disease and Injury Burden 1990–2019 Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME). 2020. Available from: https://​vizhub.​healthdata.​org/​gbd-results/​.
23.
go back to reference Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.PubMedCrossRef Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.PubMedCrossRef
29.
go back to reference Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, et al. A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore. Value in Health. 2008;11(s1):S84–90.PubMedCrossRef Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, et al. A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore. Value in Health. 2008;11(s1):S84–90.PubMedCrossRef
31.
go back to reference Jalilian H, Heydari S, Imani A, Salimi M, Mir N, Najafipour F. Economic burden of type 2 diabetes in Iran: a cost-of-illness study. Health Sci Rep. 2023;6(2):e1120.PubMedPubMedCentralCrossRef Jalilian H, Heydari S, Imani A, Salimi M, Mir N, Najafipour F. Economic burden of type 2 diabetes in Iran: a cost-of-illness study. Health Sci Rep. 2023;6(2):e1120.PubMedPubMedCentralCrossRef
32.
go back to reference Jeyaraman K, Berhane T, Hamilton M, Chandra AP, Falhammar H. Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia. BMC Endocr Disord. 2019;19(1):1.PubMedPubMedCentralCrossRef Jeyaraman K, Berhane T, Hamilton M, Chandra AP, Falhammar H. Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia. BMC Endocr Disord. 2019;19(1):1.PubMedPubMedCentralCrossRef
33.
go back to reference Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients I.: from ulceration to death, a systematic review. Int Wound J. 2016;13(5):892–903.PubMedCrossRef Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients I.: from ulceration to death, a systematic review. Int Wound J. 2016;13(5):892–903.PubMedCrossRef
34.
go back to reference Chen L, Sun S, Gao Y, Ran X. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies. Diabetes Obes Metab. 2023;25(1):36–45.PubMedCrossRef Chen L, Sun S, Gao Y, Ran X. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies. Diabetes Obes Metab. 2023;25(1):36–45.PubMedCrossRef
35.
go back to reference Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M. The direct medical costs of outpatient cares of type 2 diabetes in Iran: a retrospective study. Int J Prev Med. 2016;7:72.PubMedPubMedCentralCrossRef Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M. The direct medical costs of outpatient cares of type 2 diabetes in Iran: a retrospective study. Int J Prev Med. 2016;7:72.PubMedPubMedCentralCrossRef
36.
go back to reference Rahimitabar P, Kraemer A, Bozorgmehr K, Ebrahimi F, Takian A. Health condition of Afghan refugees residing in Iran in comparison to Germany: a systematic review of empirical studies. Int J Equity Health. 2023;22(1):16.PubMedPubMedCentralCrossRef Rahimitabar P, Kraemer A, Bozorgmehr K, Ebrahimi F, Takian A. Health condition of Afghan refugees residing in Iran in comparison to Germany: a systematic review of empirical studies. Int J Equity Health. 2023;22(1):16.PubMedPubMedCentralCrossRef
39.
go back to reference Mir H, Seyednejad F, Jalilian H, Nosratnejad S, Yousefi M. Cost of lung cancer in East Azerbaijan province, in Iran, in 2017. Int J Pharm Healthc Mark. 2020;14(3):461–70.CrossRef Mir H, Seyednejad F, Jalilian H, Nosratnejad S, Yousefi M. Cost of lung cancer in East Azerbaijan province, in Iran, in 2017. Int J Pharm Healthc Mark. 2020;14(3):461–70.CrossRef
40.
go back to reference Zarei E, Madarshahian E, Nikkhah A, Khodakarim S. Incidence of pressure ulcers in intensive care units and direct costs of treatment: Evidence from Iran. J Tissue Viability. 2019;28(2):70–4.PubMedCrossRef Zarei E, Madarshahian E, Nikkhah A, Khodakarim S. Incidence of pressure ulcers in intensive care units and direct costs of treatment: Evidence from Iran. J Tissue Viability. 2019;28(2):70–4.PubMedCrossRef
41.
go back to reference Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54.PubMedPubMedCentralCrossRef Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54.PubMedPubMedCentralCrossRef
42.
go back to reference Kapur A. Economic analysis of diabetes care. Indian J Med Res. 2007;125(3):473–82.PubMed Kapur A. Economic analysis of diabetes care. Indian J Med Res. 2007;125(3):473–82.PubMed
43.
go back to reference Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran Diabetologia. 2009;52:1520–7.PubMedCrossRef Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran Diabetologia. 2009;52:1520–7.PubMedCrossRef
44.
go back to reference Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266.PubMedCrossRef Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266.PubMedCrossRef
46.
go back to reference Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.PubMedCrossRef Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.PubMedCrossRef
47.
go back to reference Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.PubMedCrossRef Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.PubMedCrossRef
49.
go back to reference Bruno MT, Scalia G, Cassaro N, Costanzo M, Boemi S. Conservative management of CIN2p16 positive lesions in women with multiple HPV infection. 2020. Bruno MT, Scalia G, Cassaro N, Costanzo M, Boemi S. Conservative management of CIN2p16 positive lesions in women with multiple HPV infection. 2020.
50.
go back to reference Gong H-Z, Han C, Yang F-L, Wang C-F, Wang J-L, Wang M-S. Treatment delay in childhood pleural tuberculosis and associated factors. BMC Infect Dis. 2020;20(1):1–7.CrossRef Gong H-Z, Han C, Yang F-L, Wang C-F, Wang J-L, Wang M-S. Treatment delay in childhood pleural tuberculosis and associated factors. BMC Infect Dis. 2020;20(1):1–7.CrossRef
Metadata
Title
Economic burden of diabetic foot ulcer: a case of Iran
Authors
Reza Hashempour
SeyedHadi MirHashemi
Fariba Mollajafari
Soheila Damiri
Ali ArabAhmadi
Behzad Raei
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Diabetic Foot
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10873-9

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue